peptides life extension FAQ

Yes, but understand what the test measures. Telomere length testing via qPCR analyzes peripheral blood mononuclear cells, which represent immune cells. Not every tissue in your body. A lengthening in PBMCs doesn't confirm the same effect occurred in neurons, hepatocytes, or cardiac myocytes. Testing costs approximately $200–$400 through specialty labs (TeloYears, SpectraCell) and provides a population average, not individual chromosome data. If you're using Epithalon in research settings, baseline and follow-up testing every 12 months allows tracking of directional change, which is more meaningful than a single snapshot.

This is common during the first 2–3 injections and reflects immune system activation. Increased cytokine production as T-cell populations expand. Symptoms include mild fever, fatigue, and muscle aches, typically resolving within 24–48 hours. If symptoms persist beyond 72 hours or worsen, discontinue and consult your supervising physician. Persistent immune activation suggests contamination or an inappropriate immune response that requires medical evaluation.

Isolate the variable. Discontinue all compounds, wait two weeks for clearance, then reintroduce one peptide at a time with 4-week intervals between additions. This is the only way to determine which compound caused the adverse event. Stacking peptides without baseline individual tolerance testing makes troubleshooting impossible. If you develop persistent nausea, fatigue, or joint pain while running four peptides simultaneously, you have no way to identify the culprit without sequential elimination.

Avoid thymic peptides if you have active autoimmune disease. Thymalin enhances T-cell differentiation and immune surveillance, which can exacerbate autoimmune flares by amplifying the hyperactive immune response driving tissue damage. The mechanism that restores immune competence in immunosenescent elderly patients works against you when your immune system is already overactive. Consult an immunologist before considering any immune-modulating peptide if you have rheumatoid arthritis, lupus, Crohn's disease, or other autoimmune conditions.

Begin with compounds that have published human dosing from any clinical indication. Even if that indication isn't longevity. MK 677 has sarcopenia trial data, Cerebrolysin has stroke recovery data, Thymalin has immune restoration data. Use those established doses as your starting point rather than extrapolating from animal models. Run baseline bloodwork (CBC, CMP, lipid panel, IGF-1, inflammatory markers) before starting, then repeat at 3-month intervals to track biomarker changes objectively rather than relying on subjective assessment.

Lyophilized peptides should appear as a white to off-white powder compact at the bottom of the vial. Any discoloration (yellow, brown, pink) suggests oxidation or contamination. Reconstituted peptides should be clear and colorless unless the compound itself has inherent color (rare). If the solution is cloudy, has visible particles, or develops color after reconstitution, do not inject it. Aggregation and denaturation are not always visible, which is why third-party testing (HPLC, mass spectrometry) is the only definitive purity verification. We've found that peptides from non-certified sources fail purity testing 30–40% of the time in independent lab analysis.